Yabao Pharmaceutical Group Co Ltd (600351) — Capital Reinvestment Ratio
Yabao Pharmaceutical Group Co Ltd (600351) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥129.49 Million) in capital expenditures (CN¥7.58 Million). See free cash flow generation of Yabao Pharmaceutical Group Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yabao Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2001–2024)
This chart tracks Yabao Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 22 annual periods.
Annual Capital Reinvestment Ratio for Yabao Pharmaceutical Group Co Ltd (2001–2024)
Year-by-year Capital Reinvestment Ratio for Yabao Pharmaceutical Group Co Ltd from 2001 to 2024. For live market cap and broader valuation context, see Yabao Pharmaceutical Group Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | CN¥471.69 Million | CN¥34.66 Million | ▼ -63.4% |
| 2023 | 0.20x | CN¥497.55 Million | CN¥99.86 Million | ▲ +48.5% |
| 2022 | 0.14x | CN¥460.46 Million | CN¥62.23 Million | ▼ -37.8% |
| 2021 | 0.22x | CN¥437.50 Million | CN¥95.05 Million | ▲ +31.7% |
| 2020 | 0.17x | CN¥380.96 Million | CN¥62.87 Million | ▼ -55.3% |
| 2019 | 0.37x | CN¥425.17 Million | CN¥157.09 Million | ▲ +131.8% |
| 2018 | 0.16x | CN¥426.60 Million | CN¥68.01 Million | ▼ -74.0% |
| 2017 | 0.61x | CN¥161.73 Million | CN¥99.34 Million | ▲ +13.4% |
| 2016 | 0.54x | CN¥155.95 Million | CN¥84.46 Million | ▼ -23.6% |
| 2015 | 0.71x | CN¥143.47 Million | CN¥101.68 Million | ▼ -27.2% |
| 2014 | 0.97x | CN¥178.63 Million | CN¥173.84 Million | ▼ -44.2% |
| 2013 | 1.74x | CN¥56.80 Million | CN¥99.02 Million | ▼ -40.6% |
| 2011 | 2.94x | CN¥40.73 Million | CN¥119.56 Million | ▼ -70.9% |
| 2010 | 10.09x | CN¥18.57 Million | CN¥187.30 Million | ▲ +1278.1% |
| 2009 | 0.73x | CN¥368.56 Million | CN¥269.82 Million | ▼ -48.9% |
| 2008 | 1.43x | CN¥102.90 Million | CN¥147.56 Million | ▲ +384.1% |
| 2007 | 0.30x | CN¥105.69 Million | CN¥31.31 Million | ▼ -92.1% |
| 2006 | 3.77x | CN¥11.59 Million | CN¥43.70 Million | ▼ -8.7% |
| 2005 | 4.13x | CN¥26.40 Million | CN¥108.95 Million | ▲ +62.3% |
| 2004 | 2.54x | CN¥79.73 Million | CN¥202.81 Million | ▲ +125.7% |
| 2002 | 1.13x | CN¥24.29 Million | CN¥27.38 Million | ▲ +15.4% |
| 2001 | 0.98x | CN¥23.59 Million | CN¥23.04 Million | — |